Efficacy News and Research

RSS
F2G begins F901318 Phase I clinical study for treatment of aspergillus infections

F2G begins F901318 Phase I clinical study for treatment of aspergillus infections

Clinical trial to assess safety and efficacy of novel monoclonal antibody for CLL patients

Clinical trial to assess safety and efficacy of novel monoclonal antibody for CLL patients

Infinity and AbbVie enter into global collaboration to develop and commercialize duvelisib

Infinity and AbbVie enter into global collaboration to develop and commercialize duvelisib

Researchers examine role of blocking vagus nerve in weight loss

Researchers examine role of blocking vagus nerve in weight loss

Yoga program for MS patients improves physical and mental well-being

Yoga program for MS patients improves physical and mental well-being

ANP reports primary efficacy results from ATL1103 Phase II trial in patients with acromegaly

ANP reports primary efficacy results from ATL1103 Phase II trial in patients with acromegaly

BioPhotas launches Celluma ELITE for sale to Aesthetic Physician Market

BioPhotas launches Celluma ELITE for sale to Aesthetic Physician Market

Amgen seeks EMA approval for marketing talimogene laherparepvec

Amgen seeks EMA approval for marketing talimogene laherparepvec

MEI Pharma completes patient enrollment in Pracinostat Phase II trial for treatment of MDS

MEI Pharma completes patient enrollment in Pracinostat Phase II trial for treatment of MDS

Ampio updates phase III, multicenter, double-blind STEP study of Ampion for knee osteoarthritis

Ampio updates phase III, multicenter, double-blind STEP study of Ampion for knee osteoarthritis

Synthetic announces positive results from final preclinical toxicology study of SYN-004

Synthetic announces positive results from final preclinical toxicology study of SYN-004

Soligenix announces promising preliminary results from study on ricin toxin vaccine

Soligenix announces promising preliminary results from study on ricin toxin vaccine

Concordia's subsidiary signs collaboration deal with Orphan Canada for PHOTOFRIN

Concordia's subsidiary signs collaboration deal with Orphan Canada for PHOTOFRIN

Digoxin drug increases risk of adverse cardiovascular events or sudden death

Digoxin drug increases risk of adverse cardiovascular events or sudden death

New vaccine in bid to move away from needles and syringes to skin delivery procedures

New vaccine in bid to move away from needles and syringes to skin delivery procedures

Morbidity, mortality of AF patients remains high at 1 year even with good use of oral anticoagulants

Morbidity, mortality of AF patients remains high at 1 year even with good use of oral anticoagulants

Semi-soft vaginal suppository provides drug-delivery vehicle to prevent spread of HIV

Semi-soft vaginal suppository provides drug-delivery vehicle to prevent spread of HIV

Plant-based medication after cardiac surgery shows mixed results in reducing complications

Plant-based medication after cardiac surgery shows mixed results in reducing complications

Gene therapy may offer significant advantages in prevention of botulism exposure

Gene therapy may offer significant advantages in prevention of botulism exposure

Review of clinical trials based on administering antidepressants for chronic postsurgical pain

Review of clinical trials based on administering antidepressants for chronic postsurgical pain

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.